Poll Suggests Pharmaceutical Companies are Digitally Failing Patients

About The Authors

2nd April 2014 15:13 - Pharmaceutical

A recent survey of 2,000 patients, conducted by consulting firm Accenture, suggests that pharmaceutical companies are failing patients digitally.

These findings span three types of medication recipients: those on chronic medication for conditions like diabetes; short-termers who take medications as needed or for a short-lived condition, like migraines or antibiotics; and ‘lifestyle’ medication patients, which includes prescriptions for birth control and erectile dysfunction.

The survey asked patients about the types of services they want from pharmaceutical companies, including; product information, tracking and alerts, adherence support, physician referrals rewards and financial assistance. In not one of the desired patient touch-points did pharmaceutical reach at least half (50%) of respondents.

Moreover, the findings suggest that pharmaceutical companies are missing out, not only because patients want more information (48%), but because two-thirds (64%) of those polled said they were willing to trade personal information to get free, relevant content.

Findings show a clear preference for digital over print, with seven-in-ten (69%) respondents saying they want companies to email them, while two-thirds (66%) liked print materials.

Additionally, just shy of half of those polled (48%) said they want the industry to contact them through company websites while 44% wanted outreach through mobile applications.

Sign up for free insights from your sector…

Support Us...

We hope that you have found this article useful. This section is freely available for all to use. Please help support it by liking us or following us on our social media platforms:

Share this article...

For updated Pharmaceutical insights please follow us on @DJS_Pharma or use our RSS feed

Other Pharmaceutical Research Findings

Other Latest Market Research Insights

© DJS Research 2021